Paediatric long QT syndrome: clinical outcomes and therapy in the Spanish National Registry
Clicks: 13
ID: 321419
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
13 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #29 of 310 articles by views in european heart journal
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 310 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND AND AIMS: Congenital long QT syndrome (LQTS) is a heterogeneous disorder in which genotype and QTc duration modulate the risk of major arrhythmic events (MAEs), but contemporary paediatric outcome data remain limited. This study aimed to characterize clinical features, management strategies, and predictors of MAEs in a nationwide paediatric LQTS cohort. METHODS: This retrospective multicentre study analysed children (<18 years) diagnosed with LQTS across 30 tertiary centres (2004-24) using 2022 European Society of Cardiology criteria. MAEs were defined as sudden cardiac death, aborted cardiac arrest, or appropriate implantable cardioverter-defibrillator (ICD) therapy. RESULTS: The cohort included 371 children (58% male; median diagnosis age 6.0 years; interquartile range .25-11 years). Pathogenic/likely pathogenic variants were identified in 86.5%, mainly in KCNQ1, KCNH2, or SCN5A, while 5.7% harboured high-risk genotypes (Jervell-Lange-Nielsen, calmodulinopathies, CACNA1C/Timothy). Beta-blockers were prescribed in 92.4%. Over a median 6-year follow-up, 14 children (3.8%) experienced MAEs, which occurred predominantly in those with high-risk genotypes, QTc ≥550 ms or very early presentation. MAEs were rare in LQT1-3 with QTc <500 ms. Foetal/neonatal bradycardia (5.1%) correlated with high-risk genotypes and adverse outcomes. ICDs were implanted in 33 children (8.9%); 10 (30%) received appropriate therapies, and 8 (24%) experienced complications. Left cardiac sympathetic denervation was performed in 33 (8.9%), mainly high-risk patients, and was associated with >80% arrhythmia-free survival without major complications. CONCLUSIONS: In this nationwide paediatric LQTS cohort, MAEs were uncommon and clustered in children with malignant genotypes, markedly prolonged QTc and very early presentation, particularly foetal or neonatal bradycardia. These data support the current genotype and QTc-guided management strategy, with beta-blockers as the cornerstone therapy and selective use of left cardiac sympathetic denervation and ICDs in high-risk profiles.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (59 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7169622439
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Francesca Perín, Antonio J. Cartón, Francisco Bermúdez-Jiménez, Bárbara C. Fernández-Barrio, Roger Esmel-Vilomara, Laura Marcos-Fuentes, Fernando Rueda Nuñez, María del Mar Rodríguez Vázquez del Rey, Elena Montañés Delmás, A. Ayerza Casas, Belén Fernández-Tudela, María Teresa Viadero, Francisco José Castro-García, Ana Siles, Enrique Blanca Jover, Laura Caravaca-Pantoja, Andrea Bueno-Gómez, Beatriz Salamanca-Zarzuela, Paula de Vera McMullan, Gloria López-Blanco, Beatriz Plata Izquierdo, Soledad Jimenez Casso, María Isabel Robles, Miguel Ángel Matamala Morillo, L. Megías, Sandra Rocamora Salort, C. Gatta, Marta Villares Alonso, María Arroyas, Ángeles Ortega Montes, Andrea Greco, Estefanía Martinez-Barrios, Juan Jiménez‐Jáimez, Ferran Rosés‐Noguer, Georgia Sarquella‐Brugada |
| Journal | european heart journal |
| Year | 2026 |
| DOI |
10.1093/eurheartj/ehag513
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.